Medicine Man Technologies, Inc. Stock

Equities

SHWZ

US58468U1060

Pharmaceuticals

Market Closed - OTC Markets 01:44:04 2024-04-23 pm EDT 5-day change 1st Jan Change
0.68 USD 0.00% Intraday chart for Medicine Man Technologies, Inc. -4.23% +11.53%
Sales 2024 * 174M Sales 2025 * 192M Capitalization 53.21M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 0.31 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.28 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 785
Yield 2024 *
-
Yield 2025 *
-
Free-Float 77.84%
More Fundamentals * Assessed data
Dynamic Chart
Medicine Man Technologies, Inc. Provides Earnings Guidance for the Year 2024 CI
Medicine Man Technologies, Inc. Reports Goodwill Impairment for the Fourth Quarter Ended December 31, 2023 CI
Medicine Man Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Medicine Man Technologies, Inc., Q4 2023 Earnings Call, Mar 27, 2024
Earnings Flash (SHWZ) SCHWAZZE Reports Q4 Revenue $43.3M MT
Medicine Man Technologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Medicine Man Technologies, Inc. Announces CEO Changes CI
Medicine Man Technologies, Inc. Announces Resignation of Nirup Krishnamurthy as Member of the Board of Directors CI
Medicine Man Technologies, Inc. Appoints Kathy Vrabeck as Member of the Compensation Committee and Audit Committee CI
Transcript : Medicine Man Technologies, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Earnings Flash (SHWZ) SCHWAZZE Reports Q3 Revenue $46.7M MT
Medicine Man Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Medicine Man Technologies, Inc. Resignation of Jeffrey Garwood from Member of Board of Directors CI
Medicine Man Technologies, Inc. Announces Launch of Standing Akimbo Hotspot, a New Store Within A Store Concept in Fort Collins CI
Medicine Man Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
More news

Latest transcript on Medicine Man Technologies, Inc.

1 week-4.23%
Current month-17.07%
1 month-29.17%
3 months-13.92%
6 months+0.91%
Current year+11.53%
More quotes
1 week
0.62
Extreme 0.6195
0.75
1 month
0.57
Extreme 0.5675
0.97
Current year
0.57
Extreme 0.5675
1.55
1 year
0.48
Extreme 0.48
1.55
3 years
0.48
Extreme 0.48
2.95
5 years
0.48
Extreme 0.48
4.05
10 years
0.48
Extreme 0.48
5.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 23-01-15
Chairman 52 19-06-04
Chief Tech/Sci/R&D Officer - 22-06-30
Members of the board TitleAgeSince
Director/Board Member 60 Nov. 01
Director/Board Member 60 21-03-14
Director/Board Member 50 22-10-27
More insiders
Date Price Change Volume
24-04-23 0.68 0.00% 9,402
24-04-22 0.68 0.00% 44,100
24-04-19 0.68 -2.86% 20,726
24-04-18 0.7 -1.39% 29,336
24-04-17 0.7099 -0.01% 51,641

Delayed Quote OTC Markets, April 23, 2024 at 01:44 pm EDT

More quotes
Medicine Man Technologies, Inc., operating as Schwazze, is a vertically integrated multi-state cannabis operator. The Company’s business involves the cultivation, manufacturing, distribution and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly owned retail stores, licensing arrangements, and/or third-party operators and retailers. It has three segments: Retail, Wholesale and Other. The Retail segment consists of retail locations for the sale of cannabis products. The Wholesale segment consists of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products. The Other segment encompasses the Company’s general corporate operations, in-store advertisements and certain vendor promotions. It has operations in Colorado and New Mexico. The Company owns and operates 63 retail dispensaries, six cultivation facilities and three manufacturing facilities.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.68 USD
Average target price
2.657 USD
Spread / Average Target
+290.78%
Consensus

Quarterly revenue - Rate of surprise